Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

EEG-based biomarker for the identification of mild cognitive impairment via coherency analysis and iterative dynamic time warping.

Scientific reports·2026
Same author

Mitochondrial genetic variation across tissues of the human body.

Nucleic acids research·2026
Same author

Combining EEG, event-related potentials, and MRI biomarkers for detection of mild cognitive impairment: A machine learning approach.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Blood-Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer's Disease.

Journal of clinical medicine·2026
Same author

Linking eye movements, pupil responses, and brain networks in early cognitive decline.

Alzheimer's research & therapy·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Sarang Kang1, Kyu Yeong Choi1,2, Gyungah R Jun3,4,5,6,7,8,9

  • 1Gwangju Alzheimer's and Related Dementia (GARD) Cohort Research Center, Chosun University, Gwangju, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

化217 (pTau217) 显示出在预测韩国人的阿尔茨海默病 (AD) 和粉样蛋白阳性方面有很强的潜力. 这种血液生物标志物在早期AD检测中优于GFAP和NfL,甚至在认知症状出现之前.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 老年学是指老年学的学科.

背景情况:

  • 血生物标志物为早期阿尔茨海默病 (AD) 检测提供了一种非侵入性方法.
  • 化217等离子体 (pTau217) 在欧洲人群中表现有前途,但在韩国人的实用性需要进一步调查.
  • 这项研究评估了pTau217,GFAP和NfL在大规模的韩国痴呆症队列中.

研究的目的:

  • 在韩国人口中评估血pTau217,GFAP和NfL的诊断和预测能力.
  • 为了比较这些生物标志物的表现与粉样蛋白PET阳性和AD诊断.
  • 探索pTau217作为一种跨祖先生物标志物用于早期AD检测的潜力.

主要方法:

  • 在725名参与者 (认知正常,MCI,ADRD) 中,使用Simoa测定测量了pTau217,GFAP和NfL的血水平.
  • 通过PET成像来评估粉样蛋白阳性.
  • 进行了神经心理测试,APOE基因定型和病理分析.

主要成果:

  • 血pTau217,GFAP和NfL水平与阿尔茨海默氏症痴呆和粉样蛋白PET阳性有显著的相关性.
  • pTau217显示了粉样蛋白阳性 (AUC=0.935) 的最高预测值,超过了GFAP (AUC=0.822) 和NfL (AUC=0.635).
  • pTau217还显示,与GFAP (AUC=0.706) 和NfL (AUC=0.674) 相比,AD状态 (AUC=0.778) 的预测更好,并且与AD进展相关.

结论:

  • 血pTau217是一种强大的生物标志物,用于预测韩国人口中的粉样蛋白阳性和AD进展.
  • 在检测粉样蛋白阳性方面,pTau217的表现优于GFAP和NfL,这表明它在祖先之间可靠性.
  • pTau217具有早期AD检测的潜力,在认知症状出现之前识别粉样蛋白阳性.